Fetal growth restriction: a workshop report (original) (raw)

Abstract

Intrauterine growth restriction (IUGR) is associated with significantly increased perinatal morbidity and mortality as well as cardiovascular disease and glucose intolerance in adult life. A number of disorders from genetic to metabolic, vascular, coagulative, autoimmune, as well as infectious, can influence fetal growth by damaging the placenta, leading to IUGR as a result of many possible fetal, placental and maternal disorders. Strict definitions of IUGR and of its severity are needed in order to eventually distinguish among different phenotypes, such as gestational age at onset, degree of growth restriction and presence of hypoxia. This report explores and reviews some of the most recent developments in both clinical and basic research on intrauterine growth restriction, by seeking mechanisms that involve genetic factors, utero-placental nutrient availability and vascular growth factors. New exciting findings on the genomic imprinting defects potentially associated with IUGR, and the placental anomalies associated with the decreased nutrient transport are summarized. Moreover, recent data on angiogenic growth factors as well as new information arising from application of gene chip technologies are discussed. Placenta (2004), 25, 753-757 * The workshop "Fetal growth restriction" was held at the 2003 meeting of the International Federation of Placenta Association (IFPA) and European Placenta Group (EPG), held in September 2003 in Mainz, Germany.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (24)

  1. Jarvis S, Glinianaia SV, Torrioli MG, Platt M-J, Miceli M, Jouk P-S, et al. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet 2003;362:1106-11.
  2. Barker DJP. In utero programming of chronic disease. Clin Sci 1998;95:115-28.
  3. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002;417:945-8.
  4. Tin W, Wariyar UK, Hey EN. Selection biases invalidate current low birthweight for gestation standards. Br J Obstet Gynecol 1997;104:180-5.
  5. Pardi G, Cetin I, Marconi AM, Lanfranchi A, Bozzetti P, Ferrazzi E, et al. Diagnostic value of blood sampling in fetuses with growth retardation. N Engl J Med 1993;328:692-6.
  6. Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito G, Pardi G, et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory system of the severely growth restricted fetus. Ultrasound Obstet Gynecol 2002;19:140-6.
  7. Miozzo M, Simoni G. The role of imprinted genes in fetal growth. Biol Neonate 2002;81:217-28.
  8. Li Y, Behringer RR. Esxl is an X-chromosome-imprinted regulator of placental development and fetal growth. Nat Genet 1998;20:309- 11.
  9. Takahashi K, Kobayashi T, Kanayama N. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod 2000;6:1019-25.
  10. Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet 2003;64:96-103.
  11. Mahendran D, Donnai P, Glazier JD, D'Souza SW, Boyd RDH, Sibley CP. Amino acid (System A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies. Pediatr Res 1993;34:661-5.
  12. Jansson T, Wennergren M, Illsley NP. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab 1993;77:1554-62.
  13. Johansson M, Karlsson L, Wennergren M, Jansson T, Powell TL. Activity and protein expression of Na + K + ATPase are reduced in microvillous syncytiotrophoblast plasma membranes isolated from pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab 2003;88:2831-7.
  14. Johansson M, Jansson T, Glazier JD, Powell TL. Activity and expression of the Na + /H + exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies. J Clin Endocrinol Metab 2002;87: 5686- 94.
  15. Strid H, Bucht E, Jansson T, Wennergren M, Powell T. ATP-dependent Ca2 + transport across basal membrane of human syncytiotrophoblast in pregnancies complicated by diabetes or intrauterine growth restriction. Placenta 2003;24:445-52.
  16. Paolini CL, Marconi AM, Ronzoni S, Di Noio M, Fennessey PV, Pardi G, et al. Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab 2001;86:5427-32.
  17. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998;273:23629-32.
  18. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y. Identification and functional characterization of a Na + - independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999;274:19745-51.
  19. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al. Overexpression of the soluble vascular endothelial growth factor receptor (sVEGFR-1) in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003;88:5555-63.
  20. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondai S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
  21. Koga K, Osuga Y, Yoshino, Hirota Y, Ruimeng X, Hirata T, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003;88:2348-51.
  22. Raun T, Hoegh AM, Borup R, Sørensen S. Identification of genes differentially expressed in IUGR and matched controls by Gene Chip analysis. Placenta 2003;24:A9.
  23. Cetin I, Giovannini N, Alvino G, Agostoni C, Riva E, Giovannini M, et al. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships. Pediatr Res 2002;52:750-5.
  24. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226:324-8.